Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-19-002971
Filing Date
2019-12-10
Accepted
2019-12-10 16:36:58
Documents
71
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 c94708_10q.htm 10-Q 446883
2 c94708_ex31-1.htm EX-31.1 7641
3 c94708_ex31-2.htm EX-31.2 7731
4 c94708_ex32-1.htm EX-32.1 2937
5 c94708_ex32-2.htm EX-32.2 2949
  Complete submission text file 0000930413-19-002971.txt   3606698

Data Files

Seq Description Document Type Size
6 enz-20181031.xml EX-101.INS 543524
7 enz-20181031.xsd EX-101.SCH 56439
8 enz-20181031_cal.xml EX-101.CAL 59069
9 enz-20181031_def.xml EX-101.DEF 261346
10 enz-20181031_lab.xml EX-101.LAB 435556
11 enz-20181031_pre.xml EX-101.PRE 263615
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 191278082
SIC: 8071 Services-Medical Laboratories